ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
Organ Health Publications
Read Article
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kindey health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
Fetal RhD NIPT Patient Video
Watch Video
-
Empower Gene Table - 81 Gene Panel Additional Cancer Risks
Read More
-
Empower Gene Table - 81 Gene Table by Panel
Read More
-
Empower Gene Table - 40 Gene Multi-Cancer Panel
Read More
-
Women's Health Publications
Read Article
-
Have a question or comment?
Contact Us -
Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort
Gilstrop Thompson, et al. OBSTETRICS & GYNECOLOGY 2024
Read Publication
-
Prospera Heart Pediatric Brochure
Read More
-
The Tipping Point: How clinically validated MRD testing is transforming patient management in colorectal cancer
Watch Video
-
Corrine’s Journey From Fear to Empowerment—Carrier Screening for Informed Pregnancies
Read Article
-
Signatera Publications
Read Article
-
Utilization of Circulating Tumor DNA in the Surveillance Setting
Gibbs JN, Dale PS, Weatherall AL. The American Surgeon. 2023
Read Publication
-
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors
Kalashnikova E, Aushev, VA, Malashevich AK, et al. Molecular Oncology. 2023
Read Publication
-
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer
Tsimberidou AM, Alayli FA, Okrah K, et al. Journal of Experimental Medicine. 2024
Read Publication
-
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors
Hernando-Calvo A, Yang SYC, Vila-Casadesús M, et al. JCO Precis Oncol. 2024
Read Publication
-
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
Narkhede M, Tomassetti S, Iqbal M. Front. in Oncol 2024
Read Publication
-
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma
Phillipps J, Nassief G, Morecroft R, et al. NPJ Precision Oncology. 2024
Read Publication
-
Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer
Martin T, Dinerman A, Sudhaman S, et al. J Thorac Cardiovasc Surg. 2024
Read Publication
-
Clinical significance of perioperative minimal residual disease detected by circulating tumor DNA in lung cancer patients with a long follow
Ohara S, Suda K, Sudhaman S, et al. JTO Cinical and Research Reports. 2024
Read Publication
-
ctDNA as an Adjunct to Posttreatment PET for Head and Neck Cancer Recurrence Risk Assessment
Lele SJ, Adilbay D, Lewis E, et al. Otolaryngology–Head and Neck Surgery. 2024
Read Publication
-
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
F. Recio, C.S. Scalise, P. Loar et al. Gynecologic Oncology. 2024
Read Publication
-
Loading More...
